Veterinarian training courses library : Dog / Dermatology

    Dipl. ECVD
    Video time : 34 min + MCQ
    Teaching goals
    • In recent years, new therapeutic options have been developed for the management of CAD, and, in parallel with the evolution in the knowledge of the pathophysiology of this condition, a new way of looking at the manner we use these new therapies has also emerged.
    • Currently, a proactive therapeutic approach is emphasized in which, while correcting the underlying pathogenesis whenever possible, active relapses are actively prevented, through a constant control of the inflammation associated with the allergic condition.
    • In this new therapeutic approach, the management of CAD is done in two phases:
    • A first phase of REACTIVE therapy, in which the active clinical signs (pruritic and lesional being acute or chronic) is rapidly controlled in order to induce clinical remission;
    • A second phase of PROACTIVE therapy with the goal of preventing relapses, through the regular control of subclinical inflammation.